Genetically modified cells could eliminate the need for daily injections to treat type 1 diabetes, experts have revealed. 专家透露,有了基因改良细胞,1型糖尿病患者就可不必天天注射胰岛素了。 The human cell line is genetically engineered to produce, store and release insulin in response to blood sugar levels in the human body. 人类细胞系经基因改造后,可随着人体内血糖水平的变化产生、储存并释放胰岛素。 Scientists said the insulin-producing 'Melligen' cells show promise as a possible cure for type 1 diabetes. 科研人员表示,产生胰岛素的“Melligen”细胞有望成为1型糖尿病的新疗法。 |